Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo- and lympho- proliferative disorders and in hypoxic conditions

HIGHLIGHTS

• who: Carmela Fimognari and collaborators from the Department for Life Quality Studies, Studiorum-University of Bologna, Rimini, Italy, Department of Biomolecular Sciences, University of Urbino "Carlo Bo" have published the article: Antileukemic Activity of Sulforaphane in Primary Blasts from Patients Affected by Myelo- and Lympho- Proliferative Disorders and in Hypoxic Conditions, in the Journal: PLOS ONE | www.plosone.org of July/14,/2014
• what: The aim of this study was to test the antileukemic properties of SR in hematological cancers. The results of this investigation show that SR is also able to inhibit cell-cycle . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.